Genetic contribution to patent ductus arteriosus in the premature newborn

Pediatrics

Volumn 123, Issue 2, 2009, Pages 669-673

  Bhandari, Vineet ^a   Zhou, Gongfu ^a   Bizzarro, Matthew J ^a   Buhimschi, Catalin ^a   Hussain, Naveed ^b   Gruen, Jeffrey R ^a,b   Zhang, Heping ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Genetic; Neonate; Patent ductus arteriosus; Twins

Indexed keywords

STEROID;

ARTICLE; BODY WEIGHT; CHORIOAMNIONITIS; CONTROLLED STUDY; DIZYGOTIC TWINS; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; NECROTIZING ENTEROCOLITIS; NEWBORN; OXYGEN SUPPLY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; ZYGOSITY; CLINICAL TRIAL; GENETICS; MULTICENTER STUDY; RETROSPECTIVE STUDY; TWINS;

DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RETROSPECTIVE STUDIES; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 61549132605     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1117     Document Type: Article

References (38)

1. Wyllie J. Treatment of patent ductus arteriosus. Semin Neonatol. 2003;8(6):425-432
2. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966-1972
3. Ellison RC, Peckham GJ, Lang P, et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics. 1983;71(3):364-372
4. Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr. 2005;40(2):184-188
5. Bancalari E, Claure N, Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate. 2005;88(3):192-201
6. Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol. 2006;26(7):428-435
7. Vincer MJ, Allen AC, Joseph KS, Stinson DA, Scott H, Wood E. Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics. 2006;118(6). Available at: www.pediatrics.org/cgi/ content/full/118/6/e1621
8. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F464-F466
9. Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9449):1939 -1944
10. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2006;(1):CD004213
11. Aranda JV, Thomas R. Systematic review: intravenous Ibupro- fen in preterm newborns. Semin Perinatol. 2006;30(3):114-120
12. Clyman RI, Saha S, Jobe A, Oh W. Indomethacin prophylaxis for preterm infants: the impact of 2 multicentered randomized controlled trials on clinical practice. J Pediatr. 2007;150(1):46 -50, e42
13. Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr. 2004;16(2):146-151
14. Raval MV, Laughon MM, Bose CL, Phillips JD. Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost? J Pediatr Surg. 2007;42(1):69-75; discussion 75
15. Lee LC, Tillett A, Tulloh R, Yates R, Kelsall W. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr. 2006;6:15
16. Schmidt B, Roberts RS, Fanaroff A, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr. 2006;148(6):730-734
17. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med. 2000;343(10):728-730
18. Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901-1906
19. Neale MC, Boker SM, Xie G, Maes HH. Mx: Statistical Modeling. Richmond, VA: Department of Psychiatry, Medical College of Virginia; 1999
20. Hermes-DeSantis ER, Clyman RI. Patent ductus arteriosus: pathophysiology and management. J Perinatol. 2006;26(suppl 1):S14-S18; discussion S22-S13
21. Mani A, Meraji SM, Houshyar R, et al. Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus. Proc Natl Acad Sci U S A. 2002;99(23):15054-15059
22. Gelb BD. Genetic basis of congenital heart disease. Curr Opin Cardiol. 2004;19(2):110-115
23. Satoda M, Zhao F, Diaz GA, et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet. 2000;25(1):42-46
24. Loftin CD, Trivedi DB, Tiano HF, et al. Failure of ductus arte- riosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci USA. 2001;98(3):1059-1064
25. Trivedi DB, Sugimoto Y, Loftin CD. Attenuated cyclooxygen- ase-2 expression contributes to patent ductus arteriosus in preterm mice. Pediatr Res. 2006;60(6):669 -674
26. Thebaud B, Michelakis ED, Wu XC, et al. Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to pre- term rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus. Circulation. 2004;110(11):1372-1379
27. Kajimoto H, Hashimoto K, Bonnet SN, et al. Oxygen activates the rho/rho-kinase pathway and induces rhoB and ROCK-1 expression in human and rabbit ductus arteriosus by increasing mitochondria-derived reactive oxygen species: a newly recognized mechanism for sustaining ductal constriction. Circulation. 2007;115(13):1777-1788
28. Derzbach L, Treszl A, Balogh A, Vasarhelyi B, Tulassay T, Rigo JJ. Gender dependent association between perinatal morbidity and estrogen receptor-alpha Pvull polymorphism. J Perinat Med. 2005;33(5):461-462
29. Bokodi G, Derzbach L, Banyasz I, Tulassay T, Vasarhelyi B. Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates. Arch Dis Child Fetal Neonatal Ed. 2007;92(1):F25-F29
30. Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics. 2006;118(5):1858 -1863
31. De Geus EJ, Boomsma DI, Snieder H. Genetic correlation of exercise with heart rate and respiratory sinus arrhythmia. Med Sci Sports Exerc. 2003;35(8):1287-1295
32. Evans A, Van Baal GC, McCarron P, et al. The genetics of coronary heart disease: the contribution of twin studies. Twin Res. 2003;6(5):432-441
33. Williams FM, Cherkas LF, Spector TD, MacGregor AJ. A common genetic factor underlies hypertension and other cardiovascular disorders. BMC Cardiovasc Disord. 2004;4(1):20
34. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002;252(3):247-254
35. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: Premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol. 2007;109(4):1007-1019
36. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 402: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2008;111(3):805-807
37. Souter VL, Kapur RP, Nyholt DR, et al. A report of dizygous monochorionic twins. N Engl J Med. 2003;349(2):154-158
38. Cameron AH, Edwards JH, Derom R, Thiery M, Boelaert R. The value of twin surveys in the study of malformations. Eur J Obstet Gynecol Reprod Biol. 1983;14(5):347-356